Investigational Site Number : 0560001

Bruges 8000

1 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis — Recruiting now
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling